SCHEMBL8946550

SCHEMBL8946550

CCOc1ccc([N+](=O)[O-])cc1C

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.56
TDP1 Q9NUW8 3/20 0.56
TSHR P16473 2/20 0.56
MAPT P10636 5/20 0.56
KMT2A Q03164 4/20 0.56
LMNA P02545 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
CYP3A4 P08684 2/20 0.53
NPBWR1 P48145 1/20 0.50
MCHR1 Q99705 1/20 0.50
TAAR1 Q96RJ0 1/20 0.49
PTGS2 P35354 1/20 0.47
HTT P42858 3/20 0.47
POLB P06746 1/20 0.47
PDE7A Q13946 1/20 0.46
MEN1 O00255 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22381241 0.88 ALDH1A1 (0.58) ALDH1A1TDP1TSHRMAPTKMT2A
SCHEMBL1979913 0.86 ALDH1A1 (0.56) ALDH1A1TDP1TSHRMAPTKMT2A
SCHEMBL29739542 0.86 ALDH1A1 (0.56) ALDH1A1TDP1TSHRMAPTKMT2A
SCHEMBL4238772 0.86 MAPT (0.62) ALDH1A1TDP1MAPTKMT2ALMNA
SCHEMBL30365378 0.86 MAPT (0.62) ALDH1A1TDP1MAPTKMT2ALMNA
SCHEMBL12121522 0.85 ALDH1A1 (0.52) ALDH1A1TDP1TSHRMAPTKMT2A
SCHEMBL13478851 0.84 CYP19A1 (0.57) ALDH1A1TDP1TSHRMAPTKMT2A
SCHEMBL8865199 0.84 MAPT (0.55) ALDH1A1TDP1MAPTKMT2ALMNA
SCHEMBL22342651 0.83 CYP19A1 (0.60) ALDH1A1TDP1TSHRMAPTKMT2A
SCHEMBL1984504 0.83 ALDH1A1 (0.56) ALDH1A1TDP1TSHRMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2900645-A1 3-PHENYLISOXAZOLIN DERIVATIVES WITH HERBICIDAL ACTION Bayer CropScience AG (DE) 2015-08-05 EP disclosed
US-7902239-B2 Diaminotriazoles useful as inhibitors of protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-03-08 US disclosed
US-20080014189-A1 DIAMINOTRIAZOLES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED 2008-01-17 US disclosed
US-5516788-A TREATMENT OF ATHEROSCLEROSIS; ANTIISCHEMIC, ANTICARCINOGENIC AGENTS; ANTICOAGULANTS UNIVERSITY OF BATH (GB) 1996-05-14 US disclosed
WO-1992006956-A1 INDENOINDOLE COMPOUNDS UNIVERSITY OF BATH (GB) 1992-04-30 WO disclosed
EP-0481708-A1 Indenoindole compounds UNIVERSITY OF BATH (GB) 1992-04-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080014189-A1 DIAMINOTRIAZOLES USEFUL AS INHIBITORS OF PROTEIN KINASES MAP3K20, MAP3K1, MAP3K5 ALDH1A1 3235/4885TDP1 622/4885TSHR 3866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.